End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.97 CNY | +1.77% | +4.47% | -36.32% |
26/04 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
25/04 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.32% | 3.25B | |
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-14.43% | 31.67B | |
+51.20% | 24.62B | |
-14.85% | 15.65B | |
-13.87% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.62% | 8.81B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- A Chinese mRNA COVID vaccine gains its first approval - in Indonesia